Abstract
BackgroundMetastatic Spinal Cord Compression (MSCC) is a progressive, painful and disabling condition experienced by between 2.5 and 5% of cancer patients (Loblaw, Laperriere & Mackillop, 2003. Clinical Oncology (R Coll...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
